Aurinia Pharmaceuticals (AUPH) Earnings Date & Reports

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

AUPH is expected to report earnings to fall 25.00% to 11 cents per share on July 31

Aurinia Pharmaceuticals AUPH Stock Earnings Reports

Q2'25

Est.

$0.12

Q1'25

Beat

by $0.05

Q4'24

Missed

by $0.02

Q3'24

Beat

by $0.08

Q2'24

Est.

$0.01

The last earnings report on May 12 showed earnings per share of 15 cents, beating the estimate of 10 cents. With 1.83M shares outstanding, the current market capitalization sits at 1.06B.

View a ticker or compare two or three

Compare

AUPH